Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice
Lionel M. Igaz, … , John Q. Trojanowski, Virginia M.-Y. Lee
Lionel M. Igaz, … , John Q. Trojanowski, Virginia M.-Y. Lee
Published January 4, 2011
Citation Information: J Clin Invest. 2011;121(2):726-738. https://doi.org/10.1172/JCI44867.
View: Text | PDF
Research Article Neuroscience Article has an altmetric score of 11

Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice

  • Text
  • PDF
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are characterized by cytoplasmic protein aggregates in the brain and spinal cord that include TAR-DNA binding protein 43 (TDP-43). TDP-43 is normally localized in the nucleus with roles in the regulation of gene expression, and pathological cytoplasmic aggregates are associated with depletion of nuclear protein. Here, we generated transgenic mice expressing human TDP-43 with a defective nuclear localization signal in the forebrain (hTDP-43-ΔNLS), and compared them with mice expressing WT hTDP-43 (hTDP-43-WT) to determine the effects of mislocalized cytoplasmic TDP-43 on neuronal viability. Expression of either hTDP-43-ΔNLS or hTDP-43-WT led to neuron loss in selectively vulnerable forebrain regions, corticospinal tract degeneration, and motor spasticity recapitulating key aspects of FTLD and primary lateral sclerosis. Only rare cytoplasmic phosphorylated and ubiquitinated TDP-43 inclusions were seen in hTDP-43-ΔNLS mice, suggesting that cytoplasmic inclusions were not required to induce neuronal death. Instead, neurodegeneration in hTDP-43 and hTDP-43-ΔNLS–expressing neurons was accompanied by a dramatic downregulation of the endogenous mouse TDP-43. Moreover, mice expressing hTDP-43-ΔNLS exhibited profound changes in gene expression in cortical neurons. Our data suggest that perturbation of endogenous nuclear TDP-43 results in loss of normal TDP-43 function(s) and gene regulatory pathways, culminating in degeneration of selectively vulnerable affected neurons.

Authors

Lionel M. Igaz, Linda K. Kwong, Edward B. Lee, Alice Chen-Plotkin, Eric Swanson, Travis Unger, Joe Malunda, Yan Xu, Matthew J. Winton, John Q. Trojanowski, Virginia M.-Y. Lee

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 Total
Citations: 7 20 18 11 18 12 12 16 16 15 23 14 25 26 24 1 258
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (258)

Title and authors Publication Year
Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, inflammation, and neuronal senescence
Mitra J, Kodavati M, Dharmalingam P, Guerrero EN, Rao KS, Garruto RM, Hegde ML
Acta Neuropathologica Communications 2025
Cytoplasmic expression of trans-active response DNA-binding protein-43 in aged mice display hippocampal sclerosis-like degeneration and neuronal loss with reduced lifespan
Anderson AJ, Dopler MB, Arezoumandan S, Osei-Kankam D, Davis SA, Ajroud K, Lilek J, Bambakadis E, Shapiro R, Flanagan ME, Cairns NJ, Gitcho MA
Journal of Neuropathology and Experimental Neurology 2025
Membrane Charge Drives the Aggregation of TDP-43 Pathological Fragments
Corucci G, Vadukul DM, Paracini N, Laux V, Batchu KC, Aprile FA, Pastore A
Journal of the American Chemical Society 2025
Challenges of modelling TDP-43 pathology in mice.
Armas JMB, Taoro-González L, Fisher EMC, Acevedo-Arozena A
Mammalian genome : official journal of the International Mammalian Genome Society 2025
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration.
Kellett EA, Bademosi AT, Walker AK
Molecular neurodegeneration 2025
Single-cell RNA-sequencing reveals early mitochondrial dysfunction unique to motor neurons shared across FUS- and TARDBP-ALS.
Schweingruber C, Nijssen J, Mechtersheimer J, Reber S, Lebœuf M, O'Brien NL, Mei I, Hedges E, Keuper M, Benitez JA, Radoi V, Jastroch M, Ruepp MD, Hedlund E
Nature communications 2025
RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights
Rummens J, Da Cruz S
Molecular Neurodegeneration 2025
Endogenous TDP-43 mislocalization in a novel knock-in mouse model reveals DNA repair impairment, in ammation, and neuronal senescence
Mitra J, Dharmalingam P, Kodavati MM, Guerrero EN, Rao KS, Hegde ML
Research square 2024
Seeding competent TDP-43 persists in human patient and mouse muscle.
Lynch EM, Pittman S, Daw J, Ikenaga C, Chen S, Dhavale DD, Jackrel ME, Ayala YM, Kotzbauer P, Ly CV, Pestronk A, Lloyd TE, Weihl CC
bioRxiv : the preprint server for biology 2024
How do we get from hyperexcitability to excitotoxicity in amyotrophic lateral sclerosis?
Odierna GL, Vucic S, Dyer M, Dickson T, Woodhouse A, Blizzard C
Brain : a journal of neurology 2024
Antisense Oligonucleotides (ASOs) in Motor Neuron Diseases: A Road to Cure in Light and Shade.
Cantara S, Simoncelli G, Ricci C
International journal of molecular sciences 2024
Post-translational modification sites are present in hydrophilic cavities of alpha-synuclein, tau, FUS and TDP-43 fibrils: A molecular dynamics study
Nathan Kochen N, Seaney D, Vasandani V, Murray M, Braun AR, Sachs JN
Proteins 2024
Elevated nuclear TDP-43 induces constitutive exon skipping
Carmen-Orozco RP, Tsao W, Ye Y, Sinha IR, Chang K, Trinh VT, Chung W, Bowden K, Troncoso JC, Blackshaw S, Hayes LR, Sun S, Wong PC, Ling JP
Molecular Neurodegeneration 2024
Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic dysfunction and progressive motor deficits
Hu Y, Hruscha A, Pan C, Schifferer M, Schmidt MK, Nuscher B, Giera M, Kostidis S, Burhan Ö, van Bebber F, Edbauer D, Arzberger T, Haass C, Schmid B
Molecular Neurodegeneration 2024
Spinal cord neurone loss and foot placement changes in a rat knock-in model of amyotrophic lateral sclerosis Type 8
Murage B, Tan H, Mashimo T, Jackson M, Skehel PA
Brain communications 2024
CUTS RNA Biosensor for the Real-Time Detection of TDP-43 Loss-of-Function
Xie L, Merjane J, Bergmann CA, Xu J, Hurtle B, Donnelly CJ
2024
Physiological regulation of neuronal Wnt activity is essential for TDP-43 localization and function.
Zhang N, Westerhaus A, Wilson M, Wang E, Goff L, Sockanathan S
The EMBO journal 2024
Aberrant protein aggregation in amyotrophic lateral sclerosis.
Wang H, Zeng R
Journal of neurology 2024
A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in a AAV-C9ORF72 (G4C2)66 mouse model
Thompson EG, Spead O, Akerman SC, Curcio C, Zaepfel BL, Kent ER, Philips T, Vijayakumar BG, Zacco A, Zhou W, Nagappan G, Rothstein JD
bioRxiv 2024
Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD.
Chevalier E, Audrain M, Ratnam M, Ollier R, Fuchs A, Piorkowska K, Pfeifer A, Kosco-Vilbois M, Seredenina T, Afroz T
Acta neuropathologica communications 2024
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice
Horiuchi M, Watanabe S, Komine O, Takahashi E, Kaneko K, Itohara S, Shimada M, Ogi T, Yamanaka K
Acta Neuropathologica Communications 2024
CK1δ/ε-mediated TDP-43 phosphorylation contributes to early motor neuron disease toxicity in amyotrophic lateral sclerosis
Ko VI, Ong K, Kwon DY, Li X, Pietrasiewicz A, Harvey JS, Lulla M, Bhat G, Cleveland DW, Ravits JM
Acta Neuropathologica Communications 2024
Decoding TDP-43: the molecular chameleon of neurodegenerative diseases
Zeng J, Luo C, Jiang Y, Hu T, Lin B, Xie Y, Lan J, Miao J
Acta Neuropathologica Communications 2024
A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in an AAV-C9ORF72 (G4C2)66 mouse model
Thompson EG, Spead O, Akerman SC, Curcio C, Zaepfel BL, Kent ER, Philips T, Vijayakumar BG, Zacco A, Zhou W, Nagappan G, Rothstein JD
Acta Neuropathologica Communications 2024
A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in a AAV- C9ORF72 (G 4 C 2) 66 mouse model
Thompson EG, Spead O, Akerman SC, Curcio C, Zaepfel BL, Kent ER, Philips T, Vijayakumar BG, Zacco A, Zhou W, Nagappan G, Rothstein JD
Research Square 2024
Seeding competent TDP-43 persists in human patient and mouse muscle
Lynch EM, Pittman S, Daw J, Ikenaga C, Chen S, Dhavale DD, Jackrel ME, Ayala YM, Kotzbauer P, Ly CV, Pestronk A, Lloyd TE, Weihl CC
Science translational medicine 2024
Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis
Xin J, Huang S, Wen J, Li Y, Li A, Satyanarayanan SK, Yao X, Su H
Aging and Disease 2024
Molecular subtypes of ALS are associated with differences in patient prognosis
Eshima J, O\u2019Connor SA, Marschall E, Bowser R, Plaisier CL, Smith BS
Nature Communications 2023
TDP-43 Proteinopathy Specific Biomarker Development
Cordts I, Wachinger A, Scialo C, Lingor P, Polymenidou M, Buratti E, Feneberg E
Cells 2023
Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43
Keating SS, Bademosi AT, San Gil R, Walker AK
Cellular and Molecular Life Sciences 2023
Codon-optimized TDP-43 mediates neurodegeneration in a Drosophila model of ALS/FTLD
Yusuff T, Chang YC, Sang TK, Jackson GR, Chatterjee S
Frontiers in Genetics 2023
Astrocytic TDP-43 dysregulation impairs memory by modulating antiviral pathways and interferon-inducible chemokines
Licht-Murava A, Meadows SM, Palaguachi F, Song SC, Jackvony S, Bram Y, Zhou C, Schwartz RE, Froemke RC, Orr AL, Orr AG
Science Advances 2023
Opinion: more mouse models and more translation needed for ALS
Fisher EM, Greensmith L, Malaspina A, Fratta P, Hanna MG, Schiavo G, Isaacs AM, Orrell RW, Cunningham TJ, Arozena AA
Molecular Neurodegeneration 2023
Neural circuit and synaptic dysfunctions in ALS-FTD pathology
Mora S, Allodi I
Frontiers in neural circuits 2023
TDP-43 differentially propagates to induce antero- and retrograde degeneration in the corticospinal circuits in mouse focal ALS models.
Tsuboguchi S, Nakamura Y, Ishihara T, Kato T, Sato T, Koyama A, Mori H, Koike Y, Onodera O, Ueno M
Acta Neuropathologica 2023
Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis
Yabata H, Riku Y, Miyahara H, Akagi A, Sone J, Urushitani M, Yoshida M, Iwasaki Y
International journal of molecular sciences 2023
TDP-43 Epigenetic Facets and Their Neurodegenerative Implications
Gimenez J, Spalloni A, Cappelli S, Ciaiola F, Orlando V, Buratti E, Longone P
International journal of molecular sciences 2023
TDP-43 pathology is associated with increased tau burdens and seeding
Tomé SO, Tsaka G, Ronisz A, Ospitalieri S, Gawor K, Gomes LA, Otto M, von Arnim CA, Van Damme P, Van Den Bosch L, Ghebremedhin E, Laureyssen C, Sleegers K, Vandenberghe R, Rousseau F, Schymkowitz J, Thal DR
Molecular Neurodegeneration 2023
RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy
Necarsulmer JC, Simon JM, Evangelista BA, Chen Y, Tian X, Nafees S, Marquez AB, Jiang H, Wang P, Ajit D, Nikolova VD, Harper KM, Ezzell JA, Lin FC, Beltran AS, Moy SS, Cohen TJ
eLife 2023
Elevated nuclear TDP-43 induces constitutive exon skipping
Carmen-Orozco RP, Tsao W, Ye Y, Sinha IR, Chang K, Trinh V, Chung W, Bowden K, Troncoso JC, Blackshaw S, Hayes LR, Sun S, Wong PC, Ling JP
2023
Frontotemporal-TDP and LATE Neurocognitive Disorders: A Pathophysiological and Genetic Approach
Ortiz GG, Ramírez-Jirano J, Arizaga RL, Delgado-Lara DL, Torres-Sánchez ED
Brain Sciences 2023
Interaction of Proteins Involved in Neuronal Proteinopathies
Kulichikhin KY, Malikova OA, Zobnina AE, Zalutskaya NM, Rubel AA
Life Sciences 2023
Synaptic remodeling follows upper motor neuron hyperexcitability in a rodent model of TDP-43
Dyer MS, Odierna GL, Clark RM, Woodhouse A, Blizzard CA
Frontiers in cellular neuroscience 2023
Increase in hnRNPA1 Expression Suffices to Kill Motor Neurons in Transgenic Rats
Huang B, Liu X, Zhang T, Wu Q, Huang C, Xia XG, Zhou H
International journal of molecular sciences 2023
Neuronal models of TDP-43 proteinopathy display reduced axonal translation, increased oxidative stress, and defective exocytosis
Pisciottani A, Croci L, Lauria F, Marullo C, Savino E, Ambrosi A, Podini P, Marchioretto M, Casoni F, Cremona O, Taverna S, Quattrini A, Cioni JM, Viero G, Codazzi F, Consalez GG
Frontiers in cellular neuroscience 2023
Modelling amyotrophic lateral sclerosis in rodents
T Todd, L Petrucelli
Nature Reviews Neuroscience 2022
The Complex Mechanisms by Which Neurons Die Following DNA Damage in Neurodegenerative Diseases
S Shadfar, M Brocardo, J Atkin
International journal of molecular sciences 2022
Loss of mouse Stmn2 function causes motor neuropathy
I Juan, L Nash, K Smith, M Leyton-Jaimes, M Qian, J Klim, F Limone, A Dorr, A Couto, G Pintacuda, B Joseph, D Whisenant, C Noble, V Melnik, D Potter, A Holmes, A Burberry, M Verhage, K Eggan
Neuron 2022
Expanding the TDP-43 Proteinopathy Pathway From Neurons to Muscle: Physiological and Pathophysiological Functions
L Versluys, P Pereira, N Schuermans, B Paepe, J Bleecker, E Bogaert, B Dermaut
Frontiers in neuroscience 2022
Dysregulation of Translation in TDP-43 Proteinopathies: Deficits in the RNA Supply Chain and Local Protein Production
R Bjork, N Mortimore, S Loganathan, D Zarnescu
Frontiers in neuroscience 2022
Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementia.
Charif SE, Vassallu MF, Salvañal L, Igaz LM
Neural Regeneration Research 2022
A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS
Shenouda M, Xiao S, MacNair L, Lau A, Robertson J
Frontiers in neuroscience 2022
Aberrant neural activity in prefrontal pyramidal neurons lacking TDP-43 precedes neuron loss
Liang B, Thapa R, Zhang G, Moffitt C, Zhang Y, Zhang L, Johnston A, Ruby HP, Barbera G, Wong PC, Zhang Z, Chen R, Lin DT, Li Y
Progress in Neurobiology 2022
Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies
Tran NN, Lee BH
Frontiers in Cell and Developmental Biology 2022
SMN controls neuromuscular junction integrity through U7 snRNP
Tisdale S, Van Alstyne M, Simon CM, Mentis GZ, Pellizzoni L
Cell Reports 2022
TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
Riku Y, Yoshida M, Iwasaki Y, Sobue G, Katsuno M, Ishigaki S
International journal of molecular sciences 2022
O‐GlcNAcylation of TDP‐43 suppresses proteinopathies and promotes TDP‐43’s mRNA splicing activity
MJ Zhao, X Yao, P Wei, C Zhao, M Cheng, D Zhang, W Xue, WT He, W Xue, X Zuo, LL Jiang, Z Luo, J Song, WJ Shu, HY Yuan, Y Liang, H Sun, Y Zhou, Y Zhou, L Zheng, HY Hu, J Wang, HN Du
EMBO reports 2021
Autophagy and ALS: mechanistic insights and therapeutic implications
JP Chua, HD Calbiac, E Kabashi, SJ Barmada
Autophagy 2021
Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation
P Tziortzouda, LV Bosch, F Hirth
Nature Reviews Neuroscience 2021
Neuronal VCP loss of function recapitulates FTLD-TDP pathology
A Wani, J Zhu, JD Ulrich, A Eteleeb, AD Sauerbeck, SJ Reitz, K Arhzaouy, C Ikenaga, CM Yuede, SK Pittman, F Wang, S Li, BA Benitez, C Cruchaga, TT Kummer, O Harari, TF Chou, R Schröder, CS Clemen, CC Weihl
Cell Reports 2021
Distinct brain‐derived TDP‐43 strains from FTLD‐TDP subtypes induce diverse morphological TDP‐43 aggregates and spreading patterns in vitro and in vivo
S Porta, Y Xu, T Lehr, B Zhang, E Meymand, M Olufemi, A Stieber, EB Lee, JQ Trojanowski, VM Lee
Neuropathology and Applied Neurobiology 2021
Long non-coding RNA NEAT1_1 ameliorates TDP-43 toxicity in in vivo models of TDP-43 proteinopathy
K Matsukawa, MS Kukharsky, SK Park, S Park, N Watanabe, T Iwatsubo, T Hashimoto, SW Liebman, TA Shelkovnikova
RNA biology 2021
TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
R Atkinson, J Leung, J Bender, M Kirkcaldie, J Vickers, A King
Disease models & mechanisms 2021
Targeting TDP-43 Pathology Alleviates Cognitive and Motor Deficits Caused by Chronic Cerebral Hypoperfusion
SS Thammisetty, L Renaud, V Picher-Martel, YC Weng, F Calon, S Saikali, JP Julien, J Kriz
Neurotherapeutics 2021
Translational regulation in the brain by TDP-43 phase separation
J Gao, L Wang, X Ren, JR Dunn, A Peters, M Miyagi, H Fujioka, F Zhao, C Askwith, J Liang, X Wang
The Journal of Cell Biology 2021
Characterization of the human TARDBP gene promoter
M Baralle, M Romano
Scientific Reports 2021
Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration
Y Riku, D Seilhean, C Duyckaerts, S Boluda, Y Iguchi, S Ishigaki, Y Iwasaki, M Yoshida, Sobue, M Katsuno
International journal of molecular sciences 2021
Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
A Wood, Y Gurfinkel, N Polain, W Lamont, SL Rea
International journal of molecular sciences 2021
Extensive phenotypic characterisation of a human TDP-43Q331K transgenic mouse model of amyotrophic lateral sclerosis (ALS)
JA Watkins, JJ Alix, PJ Shaw, RJ Mead
Scientific Reports 2021
Cytoplasmic Human TDP-43 Mislocalization Induces Widespread Dendritic Spine Loss in Mouse Upper Motor Neurons
MS Dyer, A Woodhouse, CA Blizzard
Brain Sciences 2021
Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis
T Petrozziello, EA Bordt, AN Mills, SE Kim, E Sapp, BA Devlin, AA Obeng-Marnu, SM Farhan, AC Amaral, S Dujardin, PM Dooley, C Henstridge, DH Oakley, A Neueder, BT Hyman, TL Spires-Jones, SD Bilbo, K Vakili, ME Cudkowicz, JD Berry, M DiFiglia, MC Silva, SJ Haggarty, G Sadri-Vakili
Molecular Neurobiology 2021
Nearly 30 Years of Animal Models to Study Amyotrophic Lateral Sclerosis: A Historical Overview and Future Perspectives
T Bonifacino, RA Zerbo, M Balbi, C Torazza, G Frumento, E Fedele, G Bonanno, M Milanese
International journal of molecular sciences 2021
TDP-43 Pathology in Alzheimer’s Disease
Meneses A, Koga S, O\u2019Leary J, Dickson DW, Bu G, Zhao N
Molecular Neurodegeneration 2021
The progress in C9orf72 research: ALS/FTD pathogenesis, functions and structure
Jiang L, Zhang T, Lu K, Qi S
Small GTPases 2021
Stathmin-2: Adding another piece to the puzzle of TDP-43 proteinopathies and neurodegeneration
Jonathan D. Glass
Journal of Clinical Investigation 2020
TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons
S Nagano, J Jinno, RF Abdelhamid, Y Jin, M Shibata, S Watanabe, S Hirokawa, M Nishizawa, K Sakimura, O Onodera, H Okada, T Okada, Y Saito, J Takahashi-Fujigasaki, S Murayama, S Wakatsuki, H Mochizuki, T Araki
Acta Neuropathologica 2020
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
T Filipi, Z Hermanova, J Tureckova, O Vanatko, M Anderova
Journal of Clinical Medicine 2020
The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models
CD Libner, HE Salapa, MC Levin
International journal of molecular sciences 2020
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
TR Suk, MW Rousseaux
Molecular Neurodegeneration 2020
Phenotypic diversity in ALS and the role of poly-conformational protein misfolding
JI Ayers, DR Borchelt
Acta Neuropathologica 2020
Neuronal RNA‐binding protein dysfunction in multiple sclerosis cortex
HE Salapa, C Hutchinson, BF Popescu, MC Levin
Annals of Clinical and Translational Neurology 2020
Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
F Trojsi, G DAlvano, S Bonavita, G Tedeschi
International journal of molecular sciences 2020
A robust TDP-43 knock-in mouse model of ALS
SL Huang, LS Wu, M Lee, CW Chang, WC Cheng, YS Fang, YR Chen, PL Cheng, CK Shen
Acta Neuropathologica Communications 2020
Somatic TARDBP variants as a cause of semantic dementia
J van Rooij, MO Mol, S Melhem, P van der Wal, P Arp, F Paron, LD Kaat, H Seelaar, SS Miedema, T Oshima, BJ Eggen, A Uitterlinden, J van Meurs, RE van Kesteren, AB Smit, E Buratti, JC van Swieten
Brain 2020
Cytoplasmic Expression of the ALS/FTD-Related Protein TDP-43 Decreases Global Translation Both in vitro and in vivo
SE Charif, L Luchelli, A Vila, M Blaustein, LM Igaz
Frontiers in cellular neuroscience 2020
TDP-43 prevents retrotransposon activation in the Drosophila motor system through regulation of Dicer-2 activity
G Romano, R Klima, F Feiguin
BMC Biology 2020
Caspase-4 mediates cytoplasmic accumulation of TDP-43 in the primate brains
P Yin, X Guo, W Yang, S Yan, S Yang, T Zhao, Q Sun, Y Liu, S Li, XJ Li
Acta Neuropathologica 2019
Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis
FD Giorgio, C Maduro, EM Fisher, A Acevedo-Arozena
Disease models & mechanisms 2019
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
BA Berning, AK Walker
Frontiers in neuroscience 2019
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons
EY Liu, J Russ, CP Cali, JM Phan, A Amlie-Wolf, EB Lee
Cell Reports 2019
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
RC Hergesheimer, AA Chami, DR de Assis, P Vourch, CR Andres, P Corcia, D Lanznaster, H Blasco
Brain 2019
Suppression of Conditional TDP-43 Transgene Expression Differentially Affects Early Cognitive and Social Phenotypes in TDP-43 Mice
PR Silva, GV Nieva, LM Igaz
Frontiers in Genetics 2019
Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons
LS Wu, WC Cheng, CY Chen, MC Wu, YC Wang, YH Tseng, TJ Chuang, CK Shen
Acta Neuropathologica Communications 2019
Developmental Expression of Mutant PFN1 in Motor Neurons Impacts Neuronal Growth and Motor Performance of Young and Adult Mice
M Brettle, H Stefen, A Djordjevic, SY Fok, JW Chan, A van Hummel, J van der Hoven, M Przybyla, A Volkerling, YD Ke, F Delerue, LM Ittner, T Fath
Frontiers in molecular neuroscience 2019
TDP-43 cytoplasmic inclusion formation is disrupted in C9orf72-associated amyotrophic lateral sclerosis/frontotemporal lobar degeneration
SM Lee, S Asress, CM Hales, M Gearing, JC Vizcarra, CN Fournier, DA Gutman, LS Chin, L Li, JD Glass
2019
Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss
MA White, Z Lin, E Kim, CM Henstridge, EP Altamira, CK Hunt, E Burchill, I Callaghan, A Loreto, H Brown-Wright, R Mead, C Simmons, D Cash, MP Coleman, J Sreedharan
Acta Neuropathologica Communications 2019
Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis
L McAlary, SS Plotkin, JJ Yerbury, NR Cashman
Frontiers in molecular neuroscience 2019
RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy
HJ Chen, SD Topp, HS Hui, E Zacco, M Katarya, C McLoughlin, A King, BN Smith, C Troakes, A Pastore, CE Shaw
Brain 2019
Disruption by SaCas9 Endonuclease of HERV-Kenv, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral Sclerosis
G Ibba, C Piu, E Uleri, C Serra, A Dolei
Viruses 2018
The N Termini of TAR DNA-Binding Protein 43 (TDP43) C-Terminal Fragments Influence Degradation, Aggregation Propensity, and Morphology
YA Kasu, S Alemu, A Lamari, N Loew, CS Brower
Molecular and cellular biology 2018
Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization
AM Malik, RA Miguez, X Li, YS Ho, EL Feldman, SJ Barmada
eLife 2018
TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia
HC Archbold, KL Jackson, A Arora, K Weskamp, EM Tank, X Li, R Miguez, RD Dayton, S Tamir, RL Klein, SJ Barmada
Scientific Reports 2018
mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms
B Scherz, R Rabl, S Flunkert, S Rohler, J Neddens, N Taub, M Temmel, U Panzenboeck, V Niederkofler, R Zimmermann, B Hutter-Paier, E Buratti
PloS one 2018
Pathogenesis of Frontotemporal Lobar Degeneration: Insights From Loss of Function Theory and Early Involvement of the Caudate Nucleus
Sobue, S Ishigaki, H Watanabe
Frontiers in neuroscience 2018
Human Endogenous Retroviruses in Neurological Diseases
P Küry, A Nath, A Créange, A Dolei, P Marche, J Gold, G Giovannoni, HP Hartung, H Perron
Trends in Molecular Medicine 2018
TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons
MA Vogt, Z Ehsaei, P Knuckles, A Higginbottom, MS Helmbrecht, T Kunath, K Eggan, LA Williams, PJ Shaw, W Wurst, T Floss, AB Huber, V Taylor
Scientific Reports 2018
Differential Neurotoxicity Related to Tetracycline Transactivator and TDP-43 Expression in Conditional TDP-43 Mouse Model of Frontotemporal Lobar Degeneration
L Kukreja, R Shahidehpour, G Kim, J Keegan, KR Sadleir, T Russell, J Csernansky, M Mesulam, RJ Vassar, L Wang, H Dong, C Geula
The Journal of neuroscience : the official journal of the Society for Neuroscience 2018
Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo
S Porta, Y Xu, CR Restrepo, LK Kwong, B Zhang, HJ Brown, EB Lee, JQ Trojanowski, VM Lee
Nature Communications 2018
Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity
CY Chung, A Berson, JR Kennerdell, A Sartoris, T Unger, S Porta, HJ Kim, ER Smith, A Shilatifard, VV Deerlin, VM Lee, A Chen-Plotkin, NM Bonini
Nature Communications 2018
Reply: TDP-43 mutations increase HNRNP A1-7B through gain of splicing function
M Tétreault, JE Deshaies, S Semmler, H Sidibé, L Shkreta, K Volkening, H Soreq, MJ Strong, B Chabot, CV Velde
Brain 2018
From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis
AR Alrafiah
In vivo (Athens, Greece) 2018
Mitochondria, ER, and nuclear membrane defects reveal early mechanisms for upper motor neuron vulnerability with respect to TDP-43 pathology
M Gautam, JH Jara, N Kocak, LE Rylaarsdam, KD Kim, EH Bigio, PH Özdinler
Acta Neuropathologica 2018
Neurons selectively targeted in frontotemporal dementia reveal early stage TDP-43 pathobiology
AL Nana, M Sidhu, SE Gaus, JH Hwang, L Li, Y Park, EJ Kim, L Pasquini, IE Allen, KP Rankin, G Toller, JH Kramer, DH Geschwind, G Coppola, EJ Huang, LT Grinberg, BL Miller, WW Seeley
Acta Neuropathologica 2018
Transcriptomic Analysis of Zebrafish TDP-43 Transgenic Lines
A Lissouba, M Liao, E Kabashi, P Drapeau
Frontiers in molecular neuroscience 2018
Genetic mutations in RNA-binding proteins and their roles in ALS
K Kapeli, FJ Martinez, GW Yeo
Human Genetics 2017
Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization
W Wang, H Arakawa, L Wang, O Okolo, SL Siedlak, Y Jiang, J Gao, F Xie, RB Petersen, X Wang
Molecular Therapy 2017
New Therapeutic Avenue for ALS: Avoiding a Fatal Encounter of TDP-43 at the Mitochondria
E Hudry
Molecular Therapy 2017
Drosophila CG3303 is an essential endoribonuclease linked to TDP-43-mediated neurodegeneration
P Laneve, L Piacentini, AM Casale, D Capauto, U Gioia, U Cappucci, VD Carlo, I Bozzoni, PD Micco, V Morea, CA di Franco, E Caffarelli
Scientific Reports 2017
Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes
A Russo, R Scardigli, FL Regina, ME Murray, N Romano, DW Dickson, B Wolozin, A Cattaneo, M Ceci
Human Molecular Genetics 2017
TDP-43 expression influences amyloidβ plaque deposition and tau aggregation
SA Davis, KA Gan, JA Dowell, NJ Cairns, MA Gitcho
Neurobiology of Disease 2017
Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases
J Gao, L Wang, J Liu, F Xie, B Su, X Wang
Antioxidants 2017
TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss
RC Paolicelli, A Jawaid, CM Henstridge, A Valeri, M Merlini, JL Robinson, EB Lee, J Rose, S Appel, VM Lee, JQ Trojanowski, T Spires-Jones, PE Schulz, L Rajendran
Neuron 2017
Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects
JC Chang, DB Morton, U Pandey
PloS one 2017
Acetylation-induced TDP-43 pathology is suppressed by an HSF1-dependent chaperone program
P Wang, CM Wander, CX Yuan, MS Bereman, TJ Cohen
Nature Communications 2017
Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43A315T ALS/FTD mouse model
L Bargsted, DB Medinas, FM Traub, P Rozas, N Muñoz, M Nassif, C Jerez, A Catenaccio, FA Court, C Hetz, S Matus
Scientific Reports 2017
RNA metabolism in neurodegenerative disease
EY Liu, CP Cali, EB Lee
Disease models & mechanisms 2017
TDP-43 misexpression causes defects in dendritic growth
JJ Herzog, M Deshpande, L Shapiro, AA Rodal, S Paradis
Scientific Reports 2017
Biological Spectrum of Amyotrophic Lateral Sclerosis Prions
M Polymenidou, DW Cleveland
Cold Spring Harbor Perspectives in Medicine 2017
TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling
A Berson, A Sartoris, R Nativio, VV Deerlin, JB Toledo, S Porta, S Liu, CY Chung, BA Garcia, VM Lee, JQ Trojanowski, FB Johnson, SL Berger, NM Bonini
Current Biology 2017
Practical considerations for choosing a mouse model of Alzheimer’s disease
JL Jankowsky, H Zheng
Molecular Neurodegeneration 2017
From animal models to human disease: a genetic approach for personalized medicine in ALS
V Picher-Martel, PN Valdmanis, PV Gould, JP Julien, N Dupré
Acta Neuropathologica Communications 2016
Advances in Experimental Medicine and Biology
AC Fan, AK Leung
Advances in experimental medicine and biology 2016
The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo
H Sasaguri, J Chew, YF Xu, TF Gendron, A Garrett, CW Lee, K Jansen-West, PO Bauer, EA Perkerson, J Tong, C Stetler, YJ Zhang
Brain Research 2016
CUL2-mediated clearance of misfolded TDP-43 is paradoxically affected by VHL in oligodendrocytes in ALS
T Uchida, Y Tamaki, T Ayaki, A Shodai, S Kaji, T Morimura, Y Banno, K Nishitsuji, N Sakashita, T Maki, H Yamashita, H Ito, R Takahashi, M Urushitani
Scientific Reports 2016
Hypo- and Hyper-Assembly Diseases of RNA–Protein Complexes
S Shukla, R Parker
Trends in Molecular Medicine 2016
The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis
HJ Chen, JC Mitchell, S Novoselov, J Miller, AL Nishimura, EL Scotter, CA Vance, ME Cheetham, CE Shaw
Brain 2016
Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
F Kametani, T Obi, T Shishido, H Akatsu, S Murayama, Y Saito, M Yoshida, M Hasegawa
Scientific Reports 2016
Cytosolic localization of Fox proteins in motor neurons of G93A SOD1 mice
X Ma, PC Turnbull, EP Crapper, H Wang, A Drannik, F Jiang, S Xia, J Turnbull
Histochemistry and Cell Biology 2016
TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins
SP Mihevc, M Baralle, E Buratti, B Rogelj
Scientific Reports 2016
Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies
R Cascella, C Capitini, G Fani, CM Dobson, C Cecchi, F Chiti
The Journal of biological chemistry 2016
Depletion of TDP-43 decreases fibril and plaque β-amyloid and exacerbates neurodegeneration in an Alzheimer’s mouse model
KD LaClair, A Donde, JP Ling, YH Jeong, R Chhabra, LJ Martin, PC Wong
Acta Neuropathologica 2016
Early Cognitive/Social Deficits and Late Motor Phenotype in Conditional Wild-Type TDP-43 Transgenic Mice
JA Alfieri, PR Silva, LM Igaz
Frontiers in aging neuroscience 2016
Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies
L Guo, J Shorter
Cold Spring Harbor Perspectives in Medicine 2016
TDP-43/FUS in motor neuron disease: Complexity and challenges
EN Guerrero, H Wang, J Mitra, PM Hegde, SE Stowell, NF Liachko, BC Kraemer, RM Garruto, KS Rao, ML Hegde
Progress in Neurobiology 2016
Intravenous injection of l -BMAA induces a rat model with comprehensive characteristics of amyotrophic lateral sclerosis/Parkinson–dementia complex
KW Tian, H Jiang, BB Wang, F Zhang, S Han
Toxicology Research 2016
Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain
G Wang, H Yang, S Yan, CE Wang, X Liu, B Zhao, Z Ouyang, P Yin, Z Liu, Y Zhao, T Liu, N Fan, L Guo, S Li, XJ Li, L Lai
Molecular Neurodegeneration 2015
TDP-43 is intercellularly transmitted across axon terminals
MS Feiler, B Strobel, A Freischmidt, AM Helferich, J Kappel, BM Brewer, D Li, DR Thal, P Walther, AC Ludolph, KM Danzer, JH Weishaupt
The Journal of Cell Biology 2015
An acetylation switch controls TDP-43 function and aggregation propensity
TJ Cohen, AW Hwang, CR Restrepo, CX Yuan, JQ Trojanowski, VM Lee
Nature Communications 2015
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
EL Scotter, HJ Chen, CE Shaw
Neurotherapeutics 2015
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis
SJ Barmada
Neurotherapeutics 2015
FTD and ALS—translating mouse studies into clinical trials
LM Ittner, GM Halliday, JJ Kril, J Götz, JR Hodges, MC Kiernan
Nature Reviews Neurology 2015
Ataxin-2 Regulates RGS8 Translation in a New BAC-SCA2 Transgenic Mouse Model
W Dansithong, S Paul, KP Figueroa, MD Rinehart, S Wiest, LT Pflieger, DR Scoles, SM Pulst, HT Orr
PLoS genetics 2015
Mitochondrial dynamic abnormalities in amyotrophic lateral sclerosis
Z Jiang, W Wang, G Perry, X Zhu, X Wang
Translational Neurodegeneration 2015
Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2
J Sreedharan, LJ Neukomm, RH Brown, MR Freeman
Current Biology 2015
Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1
SJ Barmada, S Ju, A Arjun, A Batarse, HC Archbold, D Peisach, X Li, Y Zhang, EM Tank, H Qiu, EJ Huang, D Ringe, GA Petsko, S Finkbeiner
Proceedings of the National Academy of Sciences 2015
PABPN1 suppresses TDP-43 toxicity in ALS disease models
CC Chou, OM Alexeeva, S Yamada, A Pribadi, Y Zhang, B Mo, KR Williams, DC Zarnescu, W Rossoll
Human Molecular Genetics 2015
Current Protocols in Pharmacology: Rodent Models of ALS
T Philips, JD Rothstein
Current Protocols in Pharmacology: Rodent Models of ALS 2015
Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
AK Walker, KJ Spiller, G Ge, A Zheng, Y Xu, M Zhou, K Tripathy, LK Kwong, JQ Trojanowski, VM Lee
Acta Neuropathologica 2015
Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS
JC Mitchell, R Constable, E So, C Vance, E Scotter, L Glover, T Hortobagyi, ES Arnold, SC Ling, M McAlonis, SD Cruz, M Polymenidou, L Tessarolo, DW Cleveland, CE Shaw
Acta Neuropathologica Communications 2015
The Progranulin Cleavage Products, Granulins, Exacerbate TDP-43 Toxicity and Increase TDP-43 Levels
DA Salazar, VJ Butler, AR Argouarch, TY Hsu, A Mason, A Nakamura, H McCurdy, D Cox, R Ng, G Pan, WW Seeley, BL Miller, AW Kao
The Journal of neuroscience : the official journal of the Society for Neuroscience 2015
Studies of alternative isoforms provide insight into TDP-43 autoregulation and pathogenesis
S D'Alton, M Altshuler, J Lewis
RNA (New York, N.Y.) 2015
Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS
A Emde, C Eitan, LL Liou, RT Libby, N Rivkin, I Magen, I Reichenstein, H Oppenheim, R Eilam, A Silvestroni, B Alajajian, IZ Ben-Dov, J Aebischer, A Savidor, Y Levin, R Sons, SM Hammond, JM Ravits, T Moller, E Hornstein
The EMBO Journal 2015
Systems biology of neurodegenerative diseases
LB Wood, AR Winslow, SD Strasser
Integrative Biology 2015
TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways
L De Conti, MV Akinyi, R Mendoza-Maldonado, M Romano, M Baralle, E Buratti
Nucleic Acids Research 2015
An insoluble frontotemporal lobar degeneration-associated TDP-43 C-terminal fragment causes neurodegeneration and hippocampus pathology in transgenic mice
AK Walker, K Tripathy, CR Restrepo, G Ge, Y Xu, LK Kwong, JQ Trojanowski, VM Lee
Human Molecular Genetics 2015
Deep clinical and neuropathological phenotyping of Pick disease: Deep Phenotype Pick Disease
DJ Irwin, J Brettschneider, CT McMillan, F Cooper, C Olm, SE Arnold, VM van Deerlin, WW Seeley, BL Miller, EB Lee, VM Lee, M Grossman, JQ Trojanowski
Annals of Neurology 2015
Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies
YQ Li, MS Tan, JT Yu, L Tan
Molecular Neurobiology 2015
Transcriptomic Changes Due to Cytoplasmic TDP-43 Expression Reveal Dysregulation of Histone Transcripts and Nuclear Chromatin
A Amlie-Wolf, P Ryvkin, R Tong, I Dragomir, ER Suh, Y Xu, VM van Deerlin, BD Gregory, LK Kwong, JQ Trojanowski, VM Lee, LS Wang, EB Lee, E Buratti
PloS one 2015
Astrocytes expressing mutant SOD1 and TDP43 trigger motoneuron death that is mediated via sodium channels and nitroxidative stress
F Rojas, N Cortes, S Abarzua, A Dyrda, B Zundert
Frontiers in cellular neuroscience 2014
Ubiquitin pathways in neurodegenerative disease
G Atkin, H Paulson
Frontiers in molecular neuroscience 2014
Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43
C Stribl, A Samara, D Trumbach, R Peis, M Neumann, H Fuchs, V Gailus-Durner, MH de Angelis, B Rathkolb, E Wolf, J Beckers, M Horsch, F Neff, E Kremmer, S Koob, AS Reichert, W Hans, J Rozman, M Klingenspor, M Aichler, AK Walch, L Becker, T Klopstock, L Glasl, SM Holter, W Wurst, T Floss
The Journal of biological chemistry 2014
Profiling the Genes Affected by Pathogenic TDP-43 in Astrocytes
C Huang, B Huang, F Bi, LH Yan, J Tong, J Huang, XG Xia, H Zhou
Journal of Neurochemistry 2014
Dual vulnerability of TDP-43 to calpain and caspase-3 proteolysis after neurotoxic conditions and traumatic brain injury
Z Yang, F Lin, CS Robertson, KK Wang
Journal of Cerebral Blood Flow & Metabolism 2014
Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling
S D'Alton, M Altshuler, A Cannon, DW Dickson, L Petrucelli, J Lewis
PloS one 2014
A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects
T Ricketts, P McGoldrick, P Fratta, HM de Oliveira, R Kent, V Phatak, S Brandner, G Blanco, L Greensmith, A Acevedo-Arozena, EM Fisher
PloS one 2014
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD
ME Ward, A Taubes, R Chen, BL Miller, CF Sephton, JM Gelfand, S Minami, J Boscardin, LH Martens, WW Seeley, G Yu, J Herz, AJ Filiano, AE Arrant, ED Roberson, TW Kraft, RV Farese, A Green, L Gan
Journal of Experimental Medicine 2014
TDP-43—The key to understanding amyotrophic lateral sclerosis
Z Xu, C Yang
Rare Diseases 2014
A fruitful endeavor: Modeling ALS in the fruit fly
I Casci, UB Pandey
Brain Research 2014
Astrocytic TDP-43 Pathology in Alexander Disease
AK Walker, CM Daniels, JE Goldman, JQ Trojanowski, VM Lee, A Messing
The Journal of neuroscience : the official journal of the Society for Neuroscience 2014
Reversible Behavioral Phenotypes in a Conditional Mouse Model of TDP-43 Proteinopathies
JA Alfieri, NS Pino, LM Igaz
The Journal of neuroscience : the official journal of the Society for Neuroscience 2014
Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice
S Herdewyn, C Cirillo, LV Bosch, W Robberecht, PV Berghe, PV Damme
Molecular Neurodegeneration 2014
Disease-associated mutations of TDP-43 promote turnover of the protein through the proteasomal pathway.
Araki W, Minegishi S, Motoki K, Kume H, Hohjoh H, Araki YM, Tamaoka A
Molecular Neurobiology 2014
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
SC Ling, M Polymenidou, DW Cleveland
Neuron 2013
Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-type Human TDP-43 Mice
J Janssens, H Wils, G Kleinberger, G Joris, I Cuijt, CC Groote, C Broeckhoven, S Kumar-Singh
Molecular Neurobiology 2013
Tardbpl splicing rescues motor neuron and axonal development in a mutant tardbp zebrafish
CA Hewamadduma, AJ Grierson, TP Ma, L Pan, CB Moens, PW Ingham, T Ramesh, PJ Shaw
Human Molecular Genetics 2013
Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes
DC Diaper, Y Adachi, B Sutcliffe, DM Humphrey, CJ Elliott, A Stepto, ZN Ludlow, LV Broeck, P Callaerts, B Dermaut, A Al-Chalabi, CE Shaw, IM Robinson, F Hirth
Human Molecular Genetics 2013
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy
A Serio, B Bilican, SJ Barmada, DM Ando, C Zhao, R Siller, K Burr, G Haghi, D Story, AL Nishimura, MA Carrasco, HP Phatnani, C Shum, I Wilmut, T Maniatis, CE Shaw, S Finkbeiner, S Chandran
Proceedings of the National Academy of Sciences 2013
Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats
J Tong, C Huang, F Bi, Q Wu, B Huang, X Liu, F Li, H Zhou, XG Xia
The EMBO Journal 2013
Selective Forelimb Impairment in Rats Expressing a Pathological TDP-43 25 kDa C-terminal Fragment to Mimic Amyotrophic Lateral Sclerosis
RD Dayton, MA Gitcho, EA Orchard, JD Wilson, DB Wang, CD Cain, JA Johnson, YJ Zhang, L Petrucelli, JM Mathis, RL Klein
Molecular Therapy 2013
Protein aggregation in amyotrophic lateral sclerosis
AM Blokhuis, EJ Groen, M Koppers, LH Berg, RJ Pasterkamp
Acta Neuropathologica 2013
Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy
AK Clippinger, S D’Alton, WL Lin, TF Gendron, J Howard, DR Borchelt, A Cannon, Y Carlomagno, P Chakrabarty, C Cook, TE Golde, Y Levites, L Ranum, PJ Schultheis, G Xu, L Petrucelli, N Sahara, DW Dickson, B Giasson, J Lewis
Acta Neuropathologica 2013
The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons
W Wang, L Li, WL Lin, DW Dickson, L Petrucelli, T Zhang, X Wang
Human Molecular Genetics 2013
Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD
DC Diaper, Y Adachi, L Lazarou, M Greenstein, FA Simoes, AD Domenico, DA Solomon, S Lowe, R Alsubaie, D Cheng, S Buckley, DM Humphrey, CE Shaw, F Hirth
Human Molecular Genetics 2013
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders
J Janssens, CV Broeckhoven
Human Molecular Genetics 2013
Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?
K Talbot
Journal of Anatomy 2013
Reducing TDP-43 aggregation does not prevent its cytotoxicity
R Liu, G Yang, T Nonaka, T Arai, W Jia, MS Cynader
Acta Neuropathologica Communications 2013
Amyotrophic lateral sclerosis--a model of corticofugal axonal spread
H Braak, J Brettschneider, AC Ludolph, VM Lee, JQ Trojanowski, KD Tredici
Nature Reviews Neurology 2013
Downregulation of microRNA-9 in iPSC-derived neurons of FTD/ALS patients with TDP-43 mutations
Z Zhang, S Almeida, Y Lu, AL Nishimura, L Peng, D Sun, B Wu, AM Karydas, MC Tartaglia, JC Fong, BL Miller, RV Farese, MJ Moore, CE Shaw, FB Gao
PloS one 2013
Disease animal models of TDP-43 proteinopathy and their pre-clinical applications
YC Liu, PM Chiang, KJ Tsai
International journal of molecular sciences 2013
The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43
YF Xu, M Prudencio, JM Hubbard, J Tong, EC Whitelaw, K Jansen-West, C Stetler, X Cao, J Song, YJ Zhang
PloS one 2013
Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43)
A Shodai, T Morimura, A Ido, T Uchida, T Ayaki, R Takahashi, S Kitazawa, S Suzuki, M Shirouzu, T Kigawa, Y Muto, S Yokoyama, R Takahashi, R Kitahara, H Ito, N Fujiwara, M Urushitani
The Journal of biological chemistry 2013
Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila
L Zhan, KA Hanson, SH Kim, A Tare, RS Tibbetts
PloS one 2013
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43
ES Arnold, SC Ling, SC Huelga, C Lagier-Tourenne, M Polymenidou, D Ditsworth, HB Kordasiewicz, M McAlonis-Downes, O Platoshyn, PA Parone, SD Cruz, KM Clutario, D Swing, L Tessarollo, M Marsala, CE Shaw, GW Yeo, DW Cleveland
Proceedings of the National Academy of Sciences 2013
Nuclear TAR DNA-binding protein 43: A new target for amyotrophic lateral sclerosis treatment
M Zheng, Y Shi, D Fan
NEURAL REGEN RES 2013
The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons☆
D Honda, S Ishigaki, Y Iguchi, Y Fujioka, T Udagawa, A Masuda, K Ohno, M Katsuno, G Sobue
FEBS Open Bio 2013
Altered “Ribostasis”: RNA-protein granule formation or persistence in the development of degenerative disorders
M Ramaswami, JP Taylor, R Parker
Cell 2013
Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C
ME Lopez, MP Scott
Disease models & mechanisms 2013
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models
M Armakola, MJ Higgins, MD Figley, SJ Barmada, EA Scarborough, Z Diaz, X Fang, J Shorter, NJ Krogan, S Finkbeiner, RV Farese, AD Gitler
Nature Genetics 2012
RNA-mediated toxicity in neurodegenerative disease
VV Belzil, TF Gendron, L Petrucelli
Molecular and Cellular Neuroscience 2012
Frontotemporal Degeneration, the Next Therapeutic Frontier: Molecules and Animal Models for FTD drug development (Part 1 of 2 articles)
AL Boxer, M Gold, E Huey, FB Gao, EA Burton, T Chow, A Kao, B Leavitt, B Lamb, M Grether, D Knopman, NJ Cairns, IR Mackenzie, L Mitic, ED Roberson, DV Kammen, M Cantillon, K Zahs, S Salloway, J Morris, G Tong, H Feldman, H Fillit, S Dickinson, Z Khachaturian, M Sutherland, R Farese, BL Miller, J Cummings
Alzheimer's & dementia : the journal of the Alzheimer's Association 2012
Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43
A Uchida, H Sasaguri, N Kimura, M Tajiri, T Ohkubo, F Ono, F Sakaue, K Kanai, T Hirai, T Sano, K Shibuya, M Kobayashi, M Yamamoto, S Yokota, T Kubodera, M Tomori, K Sakaki, M Enomoto, Y Hirai, J Kumagai, Y Yasutomi, H Mochizuki, S Kuwabara, T Uchihara, H Mizusawa, T Yokota
Brain 2012
The Emerging Science of BMAA: Do Cyanobacteria Contribute to Neurodegenerative Disease?
W Holtcamp
Environmental Health Perspectives 2012
Misregulated RNA processing in amyotrophic Lateral Sclerosis
M Polymenidou, C Lagier-Tourenne, KR Hutt, CF Bennett, DW Cleveland, GW Yeo
Brain Research 2012
Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS
R Xia, Y Liu, L Yang, J Gal, H Zhu, J Jia
Molecular Neurodegeneration 2012
Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction
A Cannon, B Yang, J Knight, IM Farnham, Y Zhang, CA Wuertzer, S D'Alton, W Lin, M Castanedes-Casey, L Rousseau, B Scott, M Jurasic, J Howard, X Yu, R Bailey, MR Sarkisian, DW Dickson, L Petrucelli, J Lewis
Acta Neuropathologica 2012
Does a loss of TDP-43 function cause neurodegeneration?
ZS Xu
Molecular Neurodegeneration 2012
Exendin-4 Ameliorates Motor Neuron Degeneration in Cellular and Animal Models of Amyotrophic Lateral Sclerosis
Y Li, S Chigurupati, HW Holloway, M Mughal, D Tweedie, DA Bruestle, MP Mattson, Y Wang, BK Harvey, B Ray, DK Lahiri, NH Greig
PloS one 2012
Inactivation of CDK/pRb Pathway Normalizes Survival Pattern of Lymphoblasts Expressing the FTLD-Progranulin Mutation c.709-1G>A
C Alquezar, N Esteras, A Alzualde, F Moreno, MS Ayuso, AL de Munain, Á Martín-Requero
PloS one 2012
Knockdown of the Drosophila Fused in Sarcoma (FUS) Homologue Causes Deficient Locomotive Behavior and Shortening of Motoneuron Terminal Branches
H Sasayama, M Shimamura, T Tokuda, Y Azuma, T Yoshida, T Mizuno, M Nakagawa, N Fujikake, Y Nagai, M Yamaguchi
PloS one 2012
Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes
SJ Parker, J Meyerowitz, JL James, JR Liddell, T Nonaka, M Hasegawa, KM Kanninen, S Lim, BM Paterson, PS Donnelly, PJ Crouch, AR White
PloS one 2012
The Aggregation and Neurotoxicity of TDP-43 and Its ALS-Associated 25 kDa Fragment Are Differentially Affected by Molecular Chaperones in Drosophila
JM Gregory, TP Barros, S Meehan, CM Dobson, LM Luheshi
PloS one 2012
TDP-43: A new player on the AD field?
KL Youmans, B Wolozin
Experimental Neurology 2012
High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity
SH Kim, L Zhan, KA Hanson, RS Tibbetts
Human Molecular Genetics 2012
Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats
C Huang, J Tong, F Bi, Q Wu, B Huang, H Zhou, XG Xia
Human Molecular Genetics 2012
XBP1 depletion precedes ubiquitin aggregation and Golgi fragmentation in TDP-43 transgenic rats
J Tong, C Huang, F Bi, Q Wu, B Huang, H Zhou
Journal of Neurochemistry 2012
Mouse models of frontotemporal dementia
ED Roberson
Annals of Neurology 2012
Tunicamycin produces TDP-43 cytoplasmic inclusions in cultured brain organotypic slices
C Leggett, DS McGehee, J Mastrianni, W Yang, T Bai, JR Brorson
Journal of the Neurological Sciences 2012
Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS)
Y Nihei, D Ito, N Suzuki
The Journal of biological chemistry 2012
TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration
CF Sephton, B Cenik, BK Cenik, J Herz, G Yu
Biological Chemistry 2012
Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice
LS Wu, WC Cheng, CK Shen
The Journal of biological chemistry 2012
Caenorhabditis elegans RNA-processing protein TDP-1 regulates protein homeostasis and life span
T Zhang, HY Hwang, H Hao, C Talbot, J Wang
The Journal of biological chemistry 2012
A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology
T Yamashita, T Hideyama, K Hachiga, S Teramoto, J Takano, N Iwata, TC Saido, S Kwak
Nature Communications 2012
Differential expression of TAR DNA-binding protein (TDP-43) in the central nervous system of horses afflicted with equine motor neuron disease (EMND): a preliminary study of a potential pathologic marker.
El-Assaad I, Di Bari JA, Yasuda K, Divers TJ, Summers BA, de Lahunta A, Mohammed H
Veterinary Research Communications 2012
The ALS proteins FUS/TLS and TDP-43 function together in Drosophila locomotion and longevity
Ji-Wu Wang, Jonathan Brent, Andrew Tomlinson, Neil Shneider, Brian McCabe
Journal of Clinical Investigation 2011
Mutant TDP-43 in Motor Neurons Promotes Onset and Progression of ALS in Rats
Cao huang, Jianbin tong, fangfang bi, hongxia zhou, xu-gang xia
Journal of Clinical Investigation 2011
Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis
DB Wang, MA Gitcho, BC Kraemer, RL Klein
European Journal of Neuroscience 2011
Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis
DA Bosco, MJ LaVoie, GA Petsko, D Ringe
Cold Spring Harbor perspectives in biology 2011
SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments
PI Joyce, P Fratta, EM Fisher, A Acevedo-Arozena
Mammalian Genome 2011
Neurodegeneration the RNA way
AJ Renoux, PK Todd
Progress in Neurobiology 2011
Modeling human neurodegenerative diseases in transgenic systems
MA Sosa, RD Gasperi, G A.
Human Genetics 2011
Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies
A Ido, H Fukuyama, M Urushitani
International journal of molecular sciences 2011
The Seeds of Neurodegeneration: Prion-like Spreading in ALS
M Polymenidou, DW Cleveland
Cell 2011
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
EB Lee, VM Lee, JQ Trojanowski
Nature reviews. Neuroscience 2011
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies
TJ Cohen, VM Lee, JQ Trojanowski
Trends in Molecular Medicine 2011
TDP-43 Autoregulation: Implications for Disease
M Budini, E Buratti
Journal of Molecular Neuroscience 2011
Rodent Models of TDP-43 Proteinopathy: Investigating the Mechanisms of TDP-43-Mediated Neurodegeneration
TF Gendron, L Petrucelli
Journal of Molecular Neuroscience 2011
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43
M Polymenidou, C Lagier-Tourenne, KR Hutt, SC Huelga, J Moran, TY Liang, SC Ling, E Sun, E Wancewicz, C Mazur, H Kordasiewicz, Y Sedaghat, JP Donohue, L Shiue, CF Bennett, GW Yeo, DW Cleveland
Nature Neuroscience 2011
Progranulin and TDP-43: Mechanistic Links and Future Directions
S Kumar-Singh
Journal of Molecular Neuroscience 2011
Cognitive Decline Is Typical of Frontotemporal Lobar Degeneration in Transgenic Mice Expressing the 25-kDa C-Terminal Fragment of TDP-43
A Caccamo, S Majumder, S Oddo
The American Journal of Pathology 2011
Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
YF Xu, YJ Zhang, WL Lin, X Cao, C Stetler, DW Dickson, J Lewis, L Petrucelli
Molecular Neurodegeneration 2011
Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking
TJ Cohen, AW Hwang, T Unger, JQ Trojanowski, VM Lee
The EMBO Journal 2011
Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?
A Henriques, JL de Aguilar
Current genomics 2011
A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions*♦
Y Furukawa, K Kaneko, S Watanabe, K Yamanaka, N Nukina
The Journal of biological chemistry 2011
RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond
KA Hanson, SH Kim, RS Tibbetts
Wiley Interdisciplinary Reviews - RNA 2011
Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS
D Ito, N Suzuki
Neurology 2011
Understanding the role of TDP-43 and FUS/TLS in ALS and beyond
SD Cruz, DW Cleveland
Current Opinion in Neurobiology 2011
TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice
Tian T, Huang C, Tong J, Yang M, Zhou H, Xia XG
International journal of biological sciences 2011
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 3 … 10 11 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Referenced in 6 patents
414 readers on Mendeley
See more details